Compounds > theophylline
Page last updated: 2024-10-22

theophylline and Hyperlipemia

theophylline has been researched along with Hyperlipemia in 26 studies

Research Excerpts

ExcerptRelevanceReference
" The investigation was aimed at evaluating the feasibility of an animal model of hyperlipidemia for pharmacokinetic studies of theophylline in humans suffering from lipid metabolism disturbances."2.68[Comparative pharmacokinetics of theophylline in hyperlipidemia in animals and humans]. ( Górnik, W, 1996)
"Utilizing a hyperlipidemia Sprague-Dawley model and UPLC-MS/MS metabolomics, we examined how the effect of Liupao and green tea extracts on hyperlipidemia and antoxidant enzyme levels and compared their constituents."1.72Antihyperlipidemic effect and increased antioxidant enzyme levels of aqueous extracts from Liupao tea and green tea in vivo. ( Chen, H; Huang, L; Huang, S; Teng, J; Wei, B; Wu, Z; Xia, N, 2022)
"Hyperlipidemia is a risk factor for the development of cognitive dysfunction and atherosclerosis."1.46Guarana (Paullinia cupana) ameliorates memory impairment and modulates acetylcholinesterase activity in Poloxamer-407-induced hyperlipidemia in rat brain. ( Abdalla, FH; Adefegha, SA; Braun, JBS; Castilhos, LG; da Silva, CB; de Oliveira, JS; Guedes Manzoni, A; Leal, DBR; Lopes, STA; Rubin, MA; Ruchel, JB; Signor, C; Trelles, K, 2017)
" Marked decrease in area under the concentration-time curve (AUC), diminished volume of distribution, increased total body clearance, and shortened elimination half-life were observed."1.29Comparative pharmacokinetics of theophylline in rabbits and in humans with hyperlipidemia. ( Droździk, M; Gawrońska-Szklarz, B; Górnik, W; Pawlik, A; Wójcicki, J, 1996)

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-199020 (76.92)18.7374
1990's3 (11.54)18.2507
2000's0 (0.00)29.6817
2010's1 (3.85)24.3611
2020's2 (7.69)2.80

Authors

AuthorsStudies
Huang, S1
Chen, H1
Teng, J1
Wu, Z1
Huang, L1
Wei, B1
Xia, N1
Ruchel, JB2
Bernardes, VM1
Braun, JBS2
Manzoni, AG1
Passos, DF1
Castilhos, LG2
Abdalla, FH2
de Oliveira, JS2
de Andrade, CM1
Casali, EA1
da Cruz, IBM1
Leal, DBR2
Adefegha, SA1
Guedes Manzoni, A1
Trelles, K1
Signor, C1
Lopes, STA1
da Silva, CB1
Rubin, MA1
WENNERBY, S1
Dhorranintra, B1
Khunawat, P1
Patalung, BN1
Prabhan, C1
Baumann, J1
Martschick, R1
Wójcicki, J2
Górnik, W2
Pawlik, A1
Droździk, M1
Gawrońska-Szklarz, B1
Nakura, H1
Tateishi, T1
Watanabe, M1
Asoh, M1
Tanaka, M1
Kumai, T1
Kobayashi, S1
Haacke, H4
Parwaresch, MR4
Mäder, C4
Metz, G1
Specker, M1
Sterner, W1
Heisler, E1
Grahwit, G1
Rube, O1
Walldius, G1
Klimm, HD1
Lasso, M1
García Merlo, S1
Alvarez, C1
Franzone, JS1
Cirillo, R1
Reboani, MC1
Torrielli, MV1
Pernigotti, LM1
Samochowiec, L1
Bartłomowicz, B1
Kadłubowska, D1
Marona, H1
Jover Sanz, E1
Paradinas Jiménez, C1
Corporales López, L1
Martínez Robles, JV1
Möller-Hardenack, B1
Ferrer García, JL1
Ciammaichella, A1
Eaton, RP1
Kipnis, DM1
Zeller, W1
Christ, F1
Quinton, A1

Trials

3 trials available for theophylline and Hyperlipemia

ArticleYear
Hypolipidaemic effect of xantinol nicotinate: a clinical trial.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1983, Volume: 66, Issue:5

    Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Female; Humans; Hyperlipidemias; Hypolipidemic A

1983
[Therapy of hyperlipidemia with xanthinol nicotinate as opposed to low fat diet].
    Die Medizinische Welt, 1982, Jan-29, Volume: 33, Issue:4

    Topics: Adult; Aged; Cholesterol; Dietary Fats; Drug Tolerance; Humans; Hyperlipidemias; Middle Aged; Theoph

1982
[Comparative pharmacokinetics of theophylline in hyperlipidemia in animals and humans].
    Annales Academiae Medicae Stetinensis, 1996, Volume: 42

    Topics: Adult; Animals; Area Under Curve; Disease Models, Animal; Female; Humans; Hyperlipidemias; Male; Mid

1996

Other Studies

23 other studies available for theophylline and Hyperlipemia

ArticleYear
Antihyperlipidemic effect and increased antioxidant enzyme levels of aqueous extracts from Liupao tea and green tea in vivo.
    Journal of food science, 2022, Volume: 87, Issue:9

    Topics: Antioxidants; Bile Acids and Salts; Catalase; Cholesterol, LDL; Chromatography, Liquid; Ellagic Acid

2022
Lipotoxicity-associated inflammation is prevented by guarana (
    Drug and chemical toxicology, 2021, Volume: 44, Issue:5

    Topics: Adenosine; Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Caffeine; Disease Models, Anim

2021
Guarana (Paullinia cupana) ameliorates memory impairment and modulates acetylcholinesterase activity in Poloxamer-407-induced hyperlipidemia in rat brain.
    Physiology & behavior, 2017, 01-01, Volume: 168

    Topics: Acetylcholinesterase; Animals; Blood Glucose; Brain; Caffeine; Cholesterol; Hyperlipidemias; Male; M

2017
[COMPLAMINE TREATMENT OF PATIENTS WITH INCREASED SERUM CHOLESTEROL VALUES].
    Svenska lakartidningen, 1964, Sep-09, Volume: 61

    Topics: Cholesterol; Coronary Disease; Humans; Hypercholesterolemia; Hyperlipidemias; Niacin; Nicotinic Acid

1964
Comparative pharmacokinetics of theophylline in rabbits and in humans with hyperlipidemia.
    Pulmonary pharmacology, 1996, Volume: 9, Issue:3

    Topics: Adult; Animals; Dietary Fats; Female; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Phosphodie

1996
Effect of hypoalbuminemia on the disposition of theophylline. Comparative study with Sprague-Dawley rats and a mutant Sprague-Dawley hyperlipidemic strain with hypoalbuminemia.
    Drug metabolism and disposition: the biological fate of chemicals, 1998, Volume: 26, Issue:6

    Topics: Animals; Bronchodilator Agents; Hyperlipidemias; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; S

1998
[Xantinol-nicotinate in primary type-V hyperlipoproteinaemia (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1976, Sep-24, Volume: 101, Issue:39

    Topics: Adult; Aged; Body Weight; Cholesterol; Chylomicrons; Fatty Acids, Nonesterified; Female; Humans; Hyp

1976
[Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)].
    Medizinische Klinik, 1977, Jul-08, Volume: 72, Issue:27

    Topics: Adolescent; Adult; Cholesterol; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Li

1977
1-(Theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (ML 1024), a new hypolipemic agent.
    Arzneimittel-Forschung, 1977, Volume: 27, Issue:6

    Topics: Animals; Blood Pressure; Dogs; Female; Hyperlipidemias; Male; Mice; Pregnancy; Propionates; Rabbits;

1977
[Effect of lipid-lowering treatment with xanthinol-nicotinate on the carbohydrate metabolism in mature-onset diabetics and non-diabetic patients with hyperlipoproteinemias (HLP)].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1978, Issue:84

    Topics: Carbohydrate Metabolism; Diabetes Mellitus; Fatty Acids, Nonesterified; Humans; Hyperlipidemias; The

1978
Fatty acid incorporation into human adipose tissue (FIAT) in hypertriglyceridaemia.
    Acta medica Scandinavica. Supplementum, 1976, Volume: 591

    Topics: Adipose Tissue; Adult; Aged; Anesthesia; Biopsy, Needle; Fatty Acids; Female; Glucose; Glucose Toler

1976
[Drug therapy of hyperlipemia. Experiences with xanthinol nicotinate retard-capsules in a general practice].
    Medizinische Monatsschrift, 1976, Volume: 30, Issue:4

    Topics: Female; Humans; Hyperlipidemias; Male; Theophylline; Xanthinol Niacinate

1976
[The effect of xanthinol nicotinate on the serum lipids and lipoproteins of patients with primary hyperlipoproteinemia Type IIb and IV].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1976, Volume: 82 Pt 1

    Topics: Humans; Hyperlipidemias; Lipids; Lipoproteins; Theophylline; Xanthinol Niacinate

1976
[Long-term hypolipemic therapy in arteriosclerosis obliterans].
    Revista clinica espanola, 1976, Feb-29, Volume: 140, Issue:4

    Topics: Aged; Anticholesteremic Agents; Arteriosclerosis Obliterans; Diet Therapy; Dietary Fats; Humans; Hyp

1976
Effect of teomorfolin [N-(7'-theophylline acetyl)morpholine], a new drug, on dislipidaemic conditions induced in the rat.
    Drugs under experimental and clinical research, 1988, Volume: 14, Issue:5

    Topics: Adenosine Diphosphate; Animals; Blood Glucose; Diet, Atherogenic; Epoprostenol; Erythrocyte Deformab

1988
[Hypolipemic and antiatherogenic effects of 2',4' dichlorobenzoate of 7-gamma(beta-hydroxypropyl)-theophylline (HME2)].
    Acta poloniae pharmaceutica, 1988, Volume: 45, Issue:4

    Topics: Animals; Arteriosclerosis; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Rabbits; Rats; Rats,

1988
[Therapy of hyperlipemias with lipolytic drugs].
    Revista clinica espanola, 1974, Jun-15, Volume: 133, Issue:5

    Topics: Adult; Cholesterol; Drug Combinations; Esters; Fatty Acids, Nonesterified; Humans; Hyperlipidemias;

1974
[Therapy of hyperlipemia using xantinol-nicotinate].
    Medizinische Monatsschrift, 1973, Volume: 27, Issue:8

    Topics: Aged; Amino Alcohols; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Hyperlipidemia

1973
[Clinical valuation of "Plasmaclar", a new drug for the treatment of hyperlipaemias (author's transl)].
    Folia clinica internacional, 1973, Volume: 23, Issue:11

    Topics: Adult; Aged; Arteriosclerosis; Drug Combinations; Esters; Female; Humans; Hyperlipidemias; Male; Mid

1973
[On the treatment of hyperlipemia with theophylline nicotinate].
    Atti della Societa italiana di cardiologia, 1969, Jan-21, Volume: 2

    Topics: Aged; Arteriosclerosis; Cerebrovascular Disorders; Coronary Disease; Embolism; Humans; Hyperlipidemi

1969
Effects of high-carbohydrate diets on lipid and carbohydrate metabolism in the rat.
    The American journal of physiology, 1969, Volume: 217, Issue:4

    Topics: Animals; Blood Glucose; Blood Protein Electrophoresis; Body Weight; Carbohydrate Metabolism; Cholest

1969
[Control of fat clearance insufficiency in hyperlipemic atherosclerosis].
    Medizinische Klinik, 1966, Jan-28, Volume: 61, Issue:4

    Topics: Arteriosclerosis; Coronary Disease; Drug Synergism; Heparin; Humans; Hyperlipidemias; Myocardial Inf

1966
[Therapeutic actions of Pyridofylline in dyspnea, hyperlipemia and certain hepatobiliary diseases].
    Semaine therapeutique, 1966, Volume: 42, Issue:9

    Topics: Adult; Biliary Tract Diseases; Dyspnea; Female; Humans; Hyperlipidemias; Liver Diseases; Male; Pyrid

1966